Abstract
Purpose
To evaluate the association of HSD17B1 and HSD17B2 gene polymorphisms with uterine leiomyoma in Chinese women.
Methods
121 Chinese women with clinically diagnosed uterine leiomyoma and 217 healthy normal Chinese women were investigated to compare three single nucleotide polymorphisms (SNPs) (rs605059 and rs676387 of HSD17B1 gene and rs8191246 of HSD17B2 gene) by polymerase chain reaction–restriction fragment length polymorphism and DNA sequencing method.
Results
All the SNPs were polymorphisms in Chinese women. Frequencies of rs605059 AA genotype and A allele were significantly increased in patients with uterine leiomyoma compared to healthy controls (GG vs. AA, OR 0.40, 95 % CI 0.20–0.82; G vs. A, OR 0.68, 95 % CI 0.50–0.94).
Conclusion
The results suggest that the genotype of HSD17B1 rs605059 may play a role in the tumourgenesis of uterine leiomyoma.
Similar content being viewed by others
References
Haney AF (2000) Clinical decision making regarding leiomyomata: what we need in the next millenium. Environ Health Perspect 108(Suppl 5):835–839
Lethaby A, Vollenhoven B (2005) Fibroids (uterine myomatosis, leiomyomas). Clin Evid (14):2264–2282
Maruo T, Ohara N, Wang J, Matsuo H (2004) Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 10:207–220
Walker CL, Stewart EA (2005) Uterine fibroids: the elephant in the room. Science 308:1589–1592
Miettinen M, Mustonen M, Poutanen M, Isomaa V, Wickman M, Soderqvist G et al (1999) 17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Res Treat 57:175–182
Vihko P, Harkonen P, Soronen P, Torn S, Herrala A, Kurkela R et al (2004) 17Beta-hydroxysteroid dehydrogenases—their role in pathophysiology. Mol Cell Endocrinol 215:83–88
Jansson A, Gunnarsson C, Stal O (2006) Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors. Endocr Relat Cancer 13:875–884
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH (2008) T allele for VEGF-460 gene polymorphism at 5′-untranslated region is associated with higher susceptibility of leiomyoma. Biochem Genet 46:356–361
Morikawa J, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Kitao K et al (2008) Association study between catechol-O-methyltransferase polymorphisms and uterine leiomyomas in a Japanese population. Clin Exp Obstet Gynecol 35:35–40
Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA et al (2006) Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids 71:960–965
Ye Y, Cheng X, Luo HB, Liu L, Li YB, Hou YP (2008) CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Gen 25:389–394
Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, Peng CT (2004) Androgen receptor trinucleotide polymorphism in leiomyoma. J Assist Reprod Genet 21:453–457
Peltoketo H, Luu-The V, Simard J, Adamski J (1999) 17Beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 23:1–11
Mannermaa A, Peltoketo H, Winqvist R, Ponder BA, Kiviniemi H, Easton DF et al (1994) Human familial and sporadic breast cancer: analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay. Hum Genet 93:319–324
Normand T, Narod S, Labrie F, Simard J (1993) Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21. Hum Mol Genet 2:479–483
Lamp M, Peters M, Reinmaa E, Haller-Kikkatalo K, Kaart T, Kadastik U et al (2011) Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis. Gynecol Endocrinol 27:425–433
Katoh T, Tsuchiya M, Nakao H, Sasaki H, Hiroshima M, Tanaka T et al (2005) Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod 20:974–978
Lee IW, Kuo PH, Su MT, Kuan LC, Hsu CC, Kuo PL (2011) Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility. Hum Reprod 26:1585–1596
Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schonfels W et al (2011) Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocr Relat Cancer 18:265–276
Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE et al (2006) Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 66:2468–2475
Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB et al (2005) Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet 1:e68
Husen B, Psonka N, Jacob-Meisel M, Keil C, Rune GM (2000) Differential expression of 17 beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines. J Mol Endocrinol 24:135–144
Yang SJ, Fang ZJ, Gurates B, Tamura M, Miller J, Ferrer K et al (2001) Stromal PRs mediate induction of 17 beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. Mol Endocrinol 15:2093–2105
Andersson S, Moghrabi N (1997) Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 62:143–147
Moghrabi N, Head JR, Andersson S (1997) Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocr Metab 82:3872–3878
Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R et al (1997) Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res 57:3356–3359
Kuo PL, Su MT, Chen CH, Kuo PH, Hsu CC, Lee IW et al (2010) Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Fertil Steril 93:141–149
Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E et al (2006) Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers 15:1502–1508
Karageorgi S, McGrath M, Lee IM, Buring J, Kraft P, De Vivo I (2011) Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk. Gynecol Oncol 121:54–58
Acknowledgments
This work was financially supported by Opening Fund of Shanghai Key Laboratory of Forensic Medicine (Grant No. KF1002) and Research Fund for the Doctoral Program of Higher Education of China (Grant No. 200806101086).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cong, RJ., Huang, ZY., Cong, L. et al. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women. Arch Gynecol Obstet 286, 701–705 (2012). https://doi.org/10.1007/s00404-012-2328-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-012-2328-0